Male bowel cancer patients need more information about erectile dysfunction

Male bowel cancer patients are very likely to suffer from erectile dysfunction (ED) after treatment and yet the majority are not receiving adequate information about the condition, according to a study published in the British Medical Journal today.

Bowel cancer affects over 38,000 people every year in the UK with around half of patients surviving for more than five years after treatment. This figure is set to increase, says the study. Men are more likely to develop bowel cancer and many will suffer from ED after their treatment, say the authors, led by Professor Sue Wilson at the University of Birmingham.

The research team carried out a series of in-depth interviews with 28 patients in the West Midlands who had been treated for bowel cancer.

Most of the respondents experienced ED as a result of their treatment. Yet many had been uninformed and unprepared for it. Almost none were receiving adequate, effective and for the condition.

The interview results also reveal evidence of among – several respondents said their doctor or stoma nurse said ED would not matter to a patient of their age.

The authors conclude that information and treatment for ED are not routinely offered to male patients, as they are for prostate . They add that "the wide diversity of this patient group calls for greater coordination of care and consistent strategies to tackle unmet needs."

In an accompanying editorial, Larissa Temple, a colorectal surgeon at the Sloan-Kettering Institute in New York, says the study would have benefited from examples of men who had been successfully treated for erectile dysfunction so that effective systems could be identified.

Temple adds that the role of the partner merits analysis and that "this is probably an important component of sexual rehabilitation for men with colorectal cancer."

add to favorites email to friend print save as pdf

Related Stories

Cialis aids prostate cancer sex function

Oct 02, 2006

Dutch scientists say they have found a drug usually prescribed for erectile dysfunction in men increases the sexual function of prostate cancer survivors.

Bowel cancer rates fall among rich men only

Jun 01, 2011

(Medical Xpress) -- Men living in deprived areas now suffer from higher levels of bowel cancer than those from more affluent areas Glasgow academics have found.

New bowel cancer gene discovery

Nov 10, 2010

Targeting a specific genetic area linked to survival in patients with advanced bowel cancer could help increase survival rates by up to three months, new University research has found.

Recommended for you

Early hormone therapy may be safe for women's hearts

8 hours ago

(HealthDay)—Healthy women at low risk of cardiovascular disease may be able to take hormone replacement therapy soon after menopause for a short time without harming their hearts, according to a new study.

Low yield for repeat colonoscopy in some patients

9 hours ago

(HealthDay)—Repeat colonoscopies within 10 years are of little benefit to patients who had no polyps found on adequate examination; however, repeat colonoscopies do benefit patients when the baseline examination was compromised, ...

Cell's recycling center implicated in division decisions

11 hours ago

Most cells do not divide unless there is enough oxygen present to support their offspring, but certain cancer cells and other cell types circumvent this rule. Researchers at The Johns Hopkins University have now identified ...

User comments